WASHINGTON--William Paul, MD, director of the NIH Office of AIDS Research, has announced that AIDS funding will begin to shift away from clinical research toward investigator-initiated laboratory research. He said that continuation of past policies will result in only "slow, fitful progress."
WASHINGTON--William Paul, MD, director of the NIH Office of AIDSResearch, has announced that AIDS funding will begin to shiftaway from clinical research toward investigator-initiated laboratoryresearch. He said that continuation of past policies will resultin only "slow, fitful progress."
Dr. Paul appointed a new task force, chaired by Arnold Levine,a Princeton University molecular biologist, to determine researchpriorities.
Highlighting Insights From the Marginal Zone Lymphoma Workshop
Clinicians outline the significance of the MZL Workshop, where a gathering of international experts in the field discussed updates in the disease state.